Skip to main content
Clinical Trials/ACTRN12615000137594
ACTRN12615000137594
Completed
未知

Evaluation of the Impact of Exercise on the Performance of an Artificial Pancreas in Adults with Type 1 Diabetes.

St Vincents Hospital0 sites12 target enrollmentFebruary 12, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 1 Diabetes
Sponsor
St Vincents Hospital
Enrollment
12
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 12, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age \> 18 years
  • \-Type 1 Diabetes (confirmed by fasting C\-peptide level \< 50 pmol/L)
  • \-Insulin pump therapy for at least 6 months
  • \-HbA1c \< 9\.0%
  • \-Experience with a glucose sensor
  • \-Established insulin pump therapy parameters
  • \-Ability to insert/change sensor
  • \-Ability to undertake exercise as per protocol

Exclusion Criteria

  • \-Requiring \> 150 units of insulin/day
  • \-Diabetic ketoacidosis within the past 4 weeks
  • \-Hypoglycaemic unawareness (Gold score \>4\) while on Sensor Augmented Pump Therapy (SAPT) or \> 2 severe hypoglycaemic episodes within the last 12 months
  • \-Pregnancy
  • \-Renal impairment (eGFR \< 60ml/min/1\.73m2\)
  • \-Current or recent (\<4 weeks) oral or inhaled steroid therapy
  • \-Dermatological conditions involving the region of device insertion
  • \-Ischaemic heart disease or peripheral vascular disease precluding exercise
  • \-Physical limitations (e.g. impaired vision) that would compromise operation of the Closed Loop system

Outcomes

Primary Outcomes

Not specified

Similar Trials